CEO of Biomed, Dr. Thomas F. Szuran discusses the keys to success for pharma SMEs and the importance of relationship management, investments, and a culture of internal dialogue.
Could you start by introducing Biomed to our international readers?
We represent companies which are not present in Switzerland directly. Some companies choose not to enter the market by themselves given Switzerland´s small size and complexity of operations, with three national languages and the implications that has for regulations, sales and marketing
